Quick Answer
CJC-1295 and ipamorelin are peptides designed to prompt the pituitary gland to release more of the body’s own growth hormone. Small human studies suggest they may raise growth hormone and IGF-1 levels, and research on outcomes like muscle, fat loss, sleep and aging is still developing.
Who this is for: adults curious about growth hormone peptides and how they compare with approved options.
Growth Hormone Basics
Growth hormone is released by the pituitary gland in pulses, mostly during deep sleep. It drives the liver to make IGF-1, which helps regulate muscle, bone, fat and tissue repair. Levels naturally decline with age, which is one reason growth hormone and related peptides are marketed for body composition, recovery and anti-aging.
True growth hormone deficiency is a diagnosed medical condition, treated with prescription growth hormone after specific testing. Most people interested in these peptides don’t have that diagnosis.
How CJC-1295 and Ipamorelin Work
They are designed to act on growth hormone release in two different ways:
- CJC-1295 mimics growth hormone-releasing hormone (GHRH), the brain’s signal to make growth hormone. One version, “with DAC,” was designed to last for days; another, often called “no DAC” or modified GRF 1-29, is shorter acting.
- Ipamorelin mimics ghrelin at a different receptor, which may trigger a pulse of growth hormone release. It was developed with the goal of affecting cortisol and prolactin less than some older peptides.
People pair them on the theory that they might work together, though the combination hasn’t been tested in controlled trials.
Growth hormone peptides are designed to act on the body’s own hormone signals.
What the Evidence Shows
- CJC-1295: small studies in healthy adults reported higher growth hormone and IGF-1 levels for several days after injections. A later trial in another population was stopped, and development as a drug did not continue.
- Ipamorelin: it was tested in human trials for recovery of bowel function after abdominal surgery, but it did not show a clear benefit, and development stopped.
- The combination: it hasn’t been studied in controlled human trials.
Raising growth hormone or IGF-1 on a lab test is not the same as showing better muscle, fat loss, sleep, skin or longevity. There are few good trials measuring those outcomes with these peptides.
Side Effects and Who Should Be Cautious
Possible effects include water retention, tingling or numbness in the hands, joint aches, headaches, flushing, increased hunger and higher blood sugar. Because growth hormone and IGF-1 stimulate cell growth, people with an active or past cancer, diabetes or prediabetes, or who are pregnant should be cautious. Labs such as IGF-1 and blood sugar are commonly checked by providers when growth hormone is a question.
How They Compare
- Sermorelin is a shorter-acting GHRH peptide that was once FDA-approved for children with growth hormone deficiency. The brand was discontinued for business reasons.
- Tesamorelin is FDA-approved, but only to reduce abdominal fat in people with HIV-related lipodystrophy.
- Prescription growth hormone is approved for diagnosed deficiency and certain other conditions.
For body composition, strength training, adequate protein and good sleep have strong evidence behind them. See Why Muscle Mass Matters More as You Age.
Talking With a Provider About Growth Hormone Peptides
If you’re weighing a peptide you’ve read about, Allana can review your health history, labs and goals and talk through what’s known and what isn’t, so you can make an informed decision.
Wondering whether a hormone change is behind how you feel? Start with labs and a conversation.
Frequently Asked Questions
Is CJC-1295 the same as growth hormone?
No. It's designed to signal your body to release its own growth hormone rather than supplying it directly.
Will these peptides help me build muscle?
They may raise growth hormone levels, but whether that leads to meaningful muscle gain in healthy adults is still being studied.
What does "with DAC" mean?
DAC is a chemical addition designed to make CJC-1295 last longer in the body.
Are labs involved?
IGF-1 and blood sugar are commonly checked by providers when growth hormone is a question.
References
- Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006. Read more
- Ionescu M, Frohman LA. Pulsatile secretion of GH persists during continuous stimulation by CJC-1295. J Clin Endocrinol Metab. 2006. Read more
This article is for general education and is not a substitute for individual medical advice. See our medical disclaimer.
